Ardent filed in December 2018 with the Securities and Exchange Commission to raise $100 million in an IPO and planned to list on the New York Stock Exchange under the ticker symbol “ARDT.” Renaissance Capital estimated the IPO could have raised up to $400 million.
Ardent, which didn’t disclose a reason for withdrawing the IPO, is also facing a proposed class-action complaint. In late December, participants in the company’s defined contribution plan sued Ardent and other fiduciaries of its retirement savings plan in the U.S. District Court for Middle Tennessee, alleging violations of the Employee Retirement Income Security Act, according to Pensions & Investments.
More articles on healthcare finance:
22 hospital bankruptcies in 2019
Washington hospital to close this month
7 health systems with strong finances
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
